Centre for Applied Urological Research

Kingston, Ontario K7L 3J7

0 studies enrolling now · 8 studies all time

What they study most

Bladder Cancer, Bladder Neoplasms, Bladder Tumors, Cancer of the Prostate, Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Cystitis, Interstitial, Hormone Sensitive Prostate Cancer, Interstitial Cystitis, Lower Urinary Tract Symptoms (LUTS), Non-muscle Invasive Bladder Cancer, Prostate Cancer, Urinary Bladder Cancer

Studies at this site

• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
• A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer — Running, not enrolling
• A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome — Stopped early
• An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis — Completed
• Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ — Completed
• Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer — Completed
• Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis — Stopped early
• A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) — Completed